RARA CRAFT DATABASE for FDA Medical Devices
510(k)K230079

FDA DEVICE FACTS

Polyisoprene Surgical Gloves Tested for Use with Chemotherapy Drugs and Low Dermatitis Potential

Ansell Healthcare Products, LLC

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEAugust 23, 2023PRODUCT CODEKGO

Indications for use

These surgical gloves are intended to be worn by operating room personnel to protect a surgical wound from contamination. These gloves were tested for use with chemotherapy drugs, have low dermatitis potential, and are non-pyrogenic. These gloves were tested for use with Chemotherapy Drugs as per ASTM D6978-05 Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs. Tested chemotherapy drugs are as follows: Breakthrough Detection Time (Minutes) Test Chemotherapy drug & Concentration Bleomycin ( 15 mg/ml) Busulfan ( 6 mg/ml) Carmustine (BCNU ) (3.3 mg/ml) Cisplatin (1 .0 mg/ml) Cyclophosphamide (Cy toxan) (20.0 mg/ml) Cytarabine (100 mg/ml) Dacarbazine ( DTIC) (10.0 mg/ml) Daunorubicin (5 mg/ml) Docetax el (10.0 mg/ml) Doxorubicin H ydrochloride (2.0 mg /ml) Etoposide (Toposa r) (20.0 mg/ml) Fludarabine ( 25 mg/ml) Fluorou racil (50.0 mg/ml) Gemcitabine ( Gemzar) (38 mg/ml) Idarubicin ( 1 mg/ml) Ifosfamide ( 50.0 mg/ml) Irinotecan (20 .0 mg/ml) Mechlorethamine HCI (1.0 mg/ml) Melphalan (5 mg/ml) Methotrexate (25 mg/ml) Mitomycin C (0.5 mg/ml) Mitoxantrone (2.0 mg/ml) Oxaliplatin (2.0 mg/ml) Paclitaxel (Taxol) (6.0 mg/ml) Paraplatin (10 mg /ml) Thiotepa (10.0 mg/ml) Vincristine Sulfate (1.0 mg /ml) Ellence (2 mg/ml) Rituximab (10 mg/ml) >240 >240 12.6 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 >240 26.6 >240 >240 >240 Please note that the following drugs have extremely low permeation times: Carmustine (BCNU) 12.6 minutes and Thiotepa: 26.6 minutes. Warning Do not use with Carmustine and Thiotepa

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 18, 2026